Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pinedo

Showing results (291-300 of 569) with videos related to

Pageof 57
Sort By:
Clinical Colorectal Cancer|July 28, 2009
Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancerRobert Mauritz, Elisa Giovannetti, Ines J Beumer, et al.
Melanoma Research|May 17, 2007
The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesisDennis Fontijn, Monique C A Duyndam, Jeroen A M Beliën, et al.
Gynecologic Oncology|February 22, 2002
Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatinG M Kolfschoten, T M Hulscher, S M Schrier, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, G Giaccone, C J van Moorsel, et al.
Biochemical Pharmacology|September 18, 2002
The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancerAnnemarie H van Hattum, Herbert M Pinedo, Hennie M M Schlüper, et al.
Cancer Research|January 15, 1994
Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitroJ Oldenburg, A C Begg, M J van Vugt, et al.
British Journal of Cancer|September 1, 1995
Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometryN Feller, C M Kuiper, J Lankelma, et al.
Journal of Chromatography|August 3, 1990
Sensitive method for the determination of daunorubicin and all its known metabolites in plasma and heart by high-performance liquid chromatography with fluorescence detectionJ de Jong, P A Maessen, A Akkerdaas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepaS Rodenhuis, J W Baars, J H Schornagel, et al.
Cancer Treatment Reports|March 1, 1984
Pharmacokinetics of free and total platinum species after short-term infusion of cisplatinJ B Vermorken, W J van der Vijgh, I Klein, et al.
Pageof 57

Showing results (291-300 of 569) with videos related to

Sort By:
Pageof 57
Clinical Colorectal Cancer|July 28, 2009
Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancerRobert Mauritz, Elisa Giovannetti, Ines J Beumer, et al.
Melanoma Research|May 17, 2007
The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesisDennis Fontijn, Monique C A Duyndam, Jeroen A M Beliën, et al.
Gynecologic Oncology|February 22, 2002
Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatinG M Kolfschoten, T M Hulscher, S M Schrier, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, G Giaccone, C J van Moorsel, et al.
Biochemical Pharmacology|September 18, 2002
The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancerAnnemarie H van Hattum, Herbert M Pinedo, Hennie M M Schlüper, et al.
Cancer Research|January 15, 1994
Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitroJ Oldenburg, A C Begg, M J van Vugt, et al.
British Journal of Cancer|September 1, 1995
Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometryN Feller, C M Kuiper, J Lankelma, et al.
Journal of Chromatography|August 3, 1990
Sensitive method for the determination of daunorubicin and all its known metabolites in plasma and heart by high-performance liquid chromatography with fluorescence detectionJ de Jong, P A Maessen, A Akkerdaas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepaS Rodenhuis, J W Baars, J H Schornagel, et al.
Cancer Treatment Reports|March 1, 1984
Pharmacokinetics of free and total platinum species after short-term infusion of cisplatinJ B Vermorken, W J van der Vijgh, I Klein, et al.
Pageof 57